Global and Region Amyotrophic Lateral Sclerosis Drugs Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Amyotrophic Lateral Sclerosis Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Amyotrophic Lateral Sclerosis Drugsmarket, defines the market attractiveness level of Amyotrophic Lateral Sclerosis Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Amyotrophic Lateral Sclerosis Drugs industry, describes the types of Amyotrophic Lateral Sclerosis Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Amyotrophic Lateral Sclerosis Drugs market and the development prospects and opportunities of Amyotrophic Lateral Sclerosis Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Amyotrophic Lateral Sclerosis Drugs market in Chapter 13.

    By Player:

    • Ascend Laboratories

    • EISAI

    • Sanofi

    • Mitsubishi Tanabe Pharma

    • Sun Pharma

    • Covis Pharma

    • Lunan Pharma

    • CSPC Pharmaceutical

    • Mylan

    • Apotex

    • Glemark Generics

    By Type:

    • Riluzole

    • Edaravone (Radicava)

    • CoQ10

    • Butylphthalide

    • Others

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Amyotrophic Lateral Sclerosis Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Amyotrophic Lateral Sclerosis Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Amyotrophic Lateral Sclerosis Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Amyotrophic Lateral Sclerosis Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Amyotrophic Lateral Sclerosis Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Amyotrophic Lateral Sclerosis Drugs Consumption (2017-2022)

    • 7.2 United States Amyotrophic Lateral Sclerosis Drugs Consumption (2017-2022)

    • 7.3 Europe Amyotrophic Lateral Sclerosis Drugs Consumption (2017-2022)

    • 7.4 China Amyotrophic Lateral Sclerosis Drugs Consumption (2017-2022)

    • 7.5 Japan Amyotrophic Lateral Sclerosis Drugs Consumption (2017-2022)

    • 7.6 India Amyotrophic Lateral Sclerosis Drugs Consumption (2017-2022)

    • 7.7 South Korea Amyotrophic Lateral Sclerosis Drugs Consumption (2017-2022)

    8 Region and Country-wise Amyotrophic Lateral Sclerosis Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Amyotrophic Lateral Sclerosis Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Amyotrophic Lateral Sclerosis Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Amyotrophic Lateral Sclerosis Drugs Consumption Forecast (2022-2028)

    • 8.4 China Amyotrophic Lateral Sclerosis Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Amyotrophic Lateral Sclerosis Drugs Consumption Forecast (2022-2028)

    • 8.6 India Amyotrophic Lateral Sclerosis Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Amyotrophic Lateral Sclerosis Drugs Consumption Forecast (2022-2028)

    9 Global Amyotrophic Lateral Sclerosis Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Amyotrophic Lateral Sclerosis Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Riluzole Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Edaravone (Radicava) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global CoQ10 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Butylphthalide Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Amyotrophic Lateral Sclerosis Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Amyotrophic Lateral Sclerosis Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Amyotrophic Lateral Sclerosis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Riluzole Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Edaravone (Radicava) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global CoQ10 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Butylphthalide Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Amyotrophic Lateral Sclerosis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Amyotrophic Lateral Sclerosis Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Amyotrophic Lateral Sclerosis Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Amyotrophic Lateral Sclerosis Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Amyotrophic Lateral Sclerosis Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Amyotrophic Lateral Sclerosis Drugs Market Competitive Analysis

    • 14.1 Ascend Laboratories

      • 14.1.1 Ascend Laboratories Company Details

      • 14.1.2 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Product and Service

    • 14.2 EISAI

      • 14.2.1 EISAI Company Details

      • 14.2.2 EISAI Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 EISAI Amyotrophic Lateral Sclerosis Drugs Product and Service

    • 14.3 Sanofi

      • 14.3.1 Sanofi Company Details

      • 14.3.2 Sanofi Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Sanofi Amyotrophic Lateral Sclerosis Drugs Product and Service

    • 14.4 Mitsubishi Tanabe Pharma

      • 14.4.1 Mitsubishi Tanabe Pharma Company Details

      • 14.4.2 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Product and Service

    • 14.5 Sun Pharma

      • 14.5.1 Sun Pharma Company Details

      • 14.5.2 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Product and Service

    • 14.6 Covis Pharma

      • 14.6.1 Covis Pharma Company Details

      • 14.6.2 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Product and Service

    • 14.7 Lunan Pharma

      • 14.7.1 Lunan Pharma Company Details

      • 14.7.2 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Product and Service

    • 14.8 CSPC Pharmaceutical

      • 14.8.1 CSPC Pharmaceutical Company Details

      • 14.8.2 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Product and Service

    • 14.9 Mylan

      • 14.9.1 Mylan Company Details

      • 14.9.2 Mylan Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Mylan Amyotrophic Lateral Sclerosis Drugs Product and Service

    • 14.10 Apotex

      • 14.10.1 Apotex Company Details

      • 14.10.2 Apotex Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Apotex Amyotrophic Lateral Sclerosis Drugs Product and Service

    • 14.11 Glemark Generics

      • 14.11.1 Glemark Generics Company Details

      • 14.11.2 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Amyotrophic Lateral Sclerosis Drugs

    • Figure Amyotrophic Lateral Sclerosis Drugs Picture

    • Table Global Amyotrophic Lateral Sclerosis Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Amyotrophic Lateral Sclerosis Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Amyotrophic Lateral Sclerosis Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Amyotrophic Lateral Sclerosis Drugs Consumption by Country (2017-2022)

    • Figure United States Amyotrophic Lateral Sclerosis Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Amyotrophic Lateral Sclerosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Amyotrophic Lateral Sclerosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Amyotrophic Lateral Sclerosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Amyotrophic Lateral Sclerosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Amyotrophic Lateral Sclerosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Amyotrophic Lateral Sclerosis Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Amyotrophic Lateral Sclerosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Amyotrophic Lateral Sclerosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Amyotrophic Lateral Sclerosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Amyotrophic Lateral Sclerosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Amyotrophic Lateral Sclerosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Amyotrophic Lateral Sclerosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Riluzole Consumption and Growth Rate (2017-2022)

    • Figure Global Edaravone (Radicava) Consumption and Growth Rate (2017-2022)

    • Figure Global CoQ10 Consumption and Growth Rate (2017-2022)

    • Figure Global Butylphthalide Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Riluzole Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Edaravone (Radicava) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CoQ10 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Butylphthalide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Amyotrophic Lateral Sclerosis Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Amyotrophic Lateral Sclerosis Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Ascend Laboratories (Foundation Year, Company Profile and etc.)

    • Table Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Product and Service

    • Table EISAI (Foundation Year, Company Profile and etc.)

    • Table EISAI Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table EISAI Amyotrophic Lateral Sclerosis Drugs Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Amyotrophic Lateral Sclerosis Drugs Product and Service

    • Table Mitsubishi Tanabe Pharma (Foundation Year, Company Profile and etc.)

    • Table Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Product and Service

    • Table Sun Pharma (Foundation Year, Company Profile and etc.)

    • Table Sun Pharma Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharma Amyotrophic Lateral Sclerosis Drugs Product and Service

    • Table Covis Pharma (Foundation Year, Company Profile and etc.)

    • Table Covis Pharma Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Covis Pharma Amyotrophic Lateral Sclerosis Drugs Product and Service

    • Table Lunan Pharma (Foundation Year, Company Profile and etc.)

    • Table Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Product and Service

    • Table CSPC Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Amyotrophic Lateral Sclerosis Drugs Product and Service

    • Table Apotex (Foundation Year, Company Profile and etc.)

    • Table Apotex Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apotex Amyotrophic Lateral Sclerosis Drugs Product and Service

    • Table Glemark Generics (Foundation Year, Company Profile and etc.)

    • Table Glemark Generics Amyotrophic Lateral Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glemark Generics Amyotrophic Lateral Sclerosis Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.